BSE: FDC - FDC Limited

Rentabilität für sechs Monate: -32.66%
Dividendenrendite: +0.98%

Aktionsplan FDC Limited


Über das Unternehmen FDC Limited

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmic, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, and analgesics; and anti-oxidants, balanced energy and protein drinks, and vitamins and nutraceuticals, as well as various active pharmaceutical ingredients.

weitere details
It provides its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Vitcofol, Ziglim, Ziglim Plus 2, Electral, and Enerzal brand names. The company was founded in 1936 and is headquartered in Mumbai, India.

ISIN INE258B01022
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.9778
Дивиденд ао 5
Сайт https://www.fdcindia.com
Цена ао 390.15
Preisänderung pro Tag: 0% (390.15)
Preisänderung pro Woche: -2.98% (402.15)
Preisänderung pro Monat: -11.34% (440.05)
Preisänderung über 3 Monate: -22.43% (502.95)
Preisänderung über sechs Monate: -32.66% (579.35)
Preisänderung pro Jahr: -8.74% (427.5)
Preisänderung über 3 Jahre: +44.58% (269.85)
Preisänderung über 5 Jahre: +71.46% (227.55)
Preisänderung über 10 Jahre: 0% (390.15)
Preisänderung seit Jahresbeginn: -22.52% (503.55)

Unterschätzung

Name Bedeutung Grad
P/S 3.28 5
P/BV 3.04 5
P/E 20.91 7
EV/EBITDA 15.83 6
Gesamt: 6.25

Effizienz

Name Bedeutung Grad
ROA, % 12.37 4
ROE, % 14.55 4
Gesamt: 3

Dividenden

Name Bedeutung Grad
Div yield, % 0.9778 2.45
DSI 0.9286 9.29
Gesamt: 2.16

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0.000926 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 43.97 6
Rentabilität Ebitda, % -16.49 0
Rentabilität EPS, % 47.4 6
Gesamt: 3.2

ETF Aktie, % Rentabilität für das Jahr, % Dividenden, %
iShares MSCI India Small-Cap ETF 0.07869 0.4625 0.96163
SPDR S&P Emerging Markets Small Cap ETF 0.02919 5.46 3.03583
SPDR Portfolio Emerging Markets ETF 0.01949 11.59 3.1879
WisdomTree India Earnings Fund 0.01108 5.23 1.65591
Avantis Responsible Emerging Markets Equity ETF 0.0081 17.6 3.1719
Dimensional Emerging Markets Core Equity 2 ETF 0.00622 15.96 3.34087
Avantis Emerging Markets Equity ETF 0.00327 8.77 3.60513
iShares Core MSCI Total International Stock ETF 0.00273 6.4 3.25258
Dimensional Emerging Markets Value ETF 0.00011 17.07 4.19508

Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Dr. Nandan Mohan Chandavarkar Joint MD & Executive Director 24.41M
Mr. Mohan Anand Chandavarkar BR Head, MD & Director 31.81M
Mr. Sanjay B. Jain Vice President of Corporate Finance N/A
Ms. Varsharani Rajaram Katre C.S. Compliance Officer & Company Secretary N/A
Mr. Ameya Ashok Chandavarkar CEO of International Business & Executive Director 16.23M 1978 (47 Jahre)
Mr. Ashok Anand Chandavarkar Whole Time Director 17.11M
Mr. Vijay Dharmadatt Bhatt Chief Financial Officer N/A
Mr. Lalit Aggarwal President of Technical & Operations N/A
Mr. Shashank Vyapari Associate Vice President of Technical & Operations
Mr. Anant Kharche Associate Vice President of Engineering Services & Projects

Adresse: India, Mumbai, C/3 Skyvistas - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.fdcindia.com